Dec 4, 2014 Cellectar Biosciences Granted Orphan Designation for I-131-CLR1404 for the Treatment of Multiple Myeloma Learn More
Nov 25, 2014 Cellectar Biosciences Names Cameron Szakacs, Ph.D. Vice President of Clinical Development Learn More
Nov 11, 2014 Cellectar Biosciences Reports Third Quarter 2014 Financial Results and Recent Highlights Learn More
Nov 6, 2014 Cellectar Biosciences to Host Conference Call on November 11th to Discuss Third Quarter 2014 Results and Provide Quarterly Update on Development Progress Learn More